Valdoxans virkning og sikkerhed ved moderat til svær depression er undersøgt i et klinisk program med 5. 800 patienter, hvoraf 3. 900 blev behandlet med Valdoxan.
The efficacy and safety of Valdoxan in major depressive episodes have been studied in a clinical programme including 5,800 patients of whom 3,900 were treated with Valdoxan.